Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Voruciclib
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : Dana-Farber Cancer Institute | Norris Cotton Cancer Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Clinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 17, 2014
Lead Product(s) : Voruciclib
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : Dana-Farber Cancer Institute | Norris Cotton Cancer Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : P7435
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Profil Institute for Clinical Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
July 29, 2013
Lead Product(s) : P7435
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Profil Institute for Clinical Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 19, 2013
Lead Product(s) : P11187
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Phase I
Sponsor : Quintiles Inc | Miami Research Associates
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
June 11, 2013
Lead Product(s) : P11187
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Phase I
Sponsor : Quintiles Inc | Miami Research Associates
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Voruciclib
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : Melanoma Research Foundation Breakthrough Consortium
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 26, 2013
Lead Product(s) : Voruciclib
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : Melanoma Research Foundation Breakthrough Consortium
Deal Size : Inapplicable
Deal Type : Inapplicable
Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
January 30, 2013
Lead Product(s) : P7435
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
January 09, 2013
Lead Product(s) : P7435
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 07, 2013
Lead Product(s) : P2202
Therapeutic Area : Endocrinology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 28, 2012
Lead Product(s) : P2202
Therapeutic Area : Endocrinology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Tinefcon
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
June 15, 2011
Lead Product(s) : Tinefcon
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable